Company News: Page (1) of 1 - 09/28/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Shionogi To Highlight Research On Cefiderocol (S-649266), A Siderophore Cephalosporin, And S-033188, A Cap-Dependent Endonuclease Inhibitor For Treatment Of Influenza, At IDWeek 2017

  (September 28, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business Issues,Presentation,Marketing,Corporate/Company,People,Events,USA, Inc.,Medicine,Disease,healthcare,Surgery,Medication,Science,Lifestyle,Medical,Biology,Adults,Children,Women,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved